Difference between revisions of "DIABETES MELLITUS-HTN MANAGEMENT"
(Imported from text file) |
(Imported from text file) |
||
| Line 1: | Line 1: | ||
===== [[Summary Article|'''SUMMARY''']] ===== | ===== [[Summary Article|'''SUMMARY''']] ===== | ||
American Diabetes Association Standards of Care 2019 for HTN management: | American Diabetes Association Standards of Care 2019 for HTN management: | ||
<br/> | |||
<br/>1. General goal <140/90mmHg | <br/>1. General goal <140/90mmHg | ||
<br/>2. Lower in some patients particularly younger or albuminuria if achievable without significant burden 3. Lifestyle modification first ACE inhibitors or ARB generally first line drug , especially if albuminuria | <br/>2. Lower in some patients particularly younger or albuminuria if achievable without significant burden 3. Lifestyle modification first ACE inhibitors or ARB generally first line drug , especially if albuminuria | ||
Latest revision as of 02:29, 21 March 2023
SUMMARY
American Diabetes Association Standards of Care 2019 for HTN management:
1. General goal <140/90mmHg
2. Lower in some patients particularly younger or albuminuria if achievable without significant burden 3. Lifestyle modification first ACE inhibitors or ARB generally first line drug , especially if albuminuria
4. May require multiple drug therapies but not combined ACE and A2RB (which can worsen renal function)
Reference(s)
Wilkinson, I., Furmedge, D. and Sinharay, R. (2017). Oxford handbook of clinical medicine. Oxford: Oxford University Press. Get it on Amazon.
Feather, A., Randall, D. and Waterhouse, M. (2020). Kumar And Clark’s Clinical Medicine. 10th ed. S.L.: Elsevier Health Sciences. Get it on Amazon.
Hannaman, R. A., Bullock, L., Hatchell, C. A., & Yoffe, M. (2016). Internal medicine review core curriculum, 2017-2018. CO Springs, CO: MedStudy.
Therapeutic Guidelines. Melbourne: Therapeutic Guidelines Limited. https://www.tg.org.au [Accessed 2021].
